{
    "clinical_study": {
        "@rank": "13318", 
        "acronym": "ACTION", 
        "arm_group": [
            {
                "arm_group_label": "BG00002", 
                "arm_group_type": "Experimental", 
                "description": "a single dose of BG00002"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "a single dose of placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary objective of the study is to determine whether one 300 mg dose of intravenous\n      (IV) BG00002 reduces change in infarct volume from Baseline to Day 5 on magnetic resonance\n      imaging (MRI) in subjects with acute ischemic stroke when given at \u22646 hours or at >6 to \u22649\n      hours from when they were last known normal (LKN).\n\n      The secondary objectives of this study in this study population are as follows:  To assess\n      the efficacy of BG00002 on change in infarct volume from Baseline to Day 30; To assess\n      efficacy of BG00002 on change in infarct volume from 24 hours to Day 5 and Day 30;  To\n      assess the efficacy of BG00002 on clinical measures of stroke outcome;  To assess the safety\n      of BG00002 in subjects with acute ischemic stroke"
        }, 
        "brief_title": "Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Ischemic Stroke", 
        "condition_browse": {
            "mesh_term": [
                "Ischemia", 
                "Stroke", 
                "Cerebral Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Key Inclusion Criteria:\n\n          -  Diagnosis of acute ischemic stroke.\n\n          -  Score of \u22656 points on the National Institute of Health Stroke Scale (NIHSS) at\n             Screening.\n\n          -  At least 1 acute infarct with largest diameter of more than 2 cm on Baseline brain\n             diffusion-weighted imaging (DWI).\n\n          -  Participants who have received reperfusion therapy may be eligible to participate but\n             must meet all eligibility criteria and perform the Baseline study magnetic resonance\n             imaging (MRI) after reperfusion therapy has been completed.\n\n          -  Subjects of childbearing potential must practice effective contraception during the\n             study and be willing and able to continue contraception for at least 3 months after\n             their dose of study treatment.\n\n        Key Exclusion Criteria:\n\n          -  Presence of any intracranial hemorrhage (ICH) on head computed tomography (CT) or\n             non-petechial ICH on screening MRI.\n\n          -  Stroke isolated to the brainstem.\n\n          -  Presence of coma\n\n          -  Expected to die OR unable to be evaluated within 5 days.\n\n          -  Hypotension requiring the use of intravenous (IV) vasopressor support or systolic\n             blood pressure <90 mmHg at the time of randomization.\n\n          -  Known prior treatment with natalizumab.\n\n          -  Immunocompromised subjects, as determined by the Investigator.\n\n          -  History of progressive multifocal leukoencephalopathy (PML).\n\n          -  Contraindications to MRI, e.g., implanted pacemaker or other contraindicated\n             implanted metal devices, history of or risk for side effects from gadolinium, or\n             claustrophobia that cannot be medically managed.\n\n        NOTE: Other protocol-defined inclusion/exclusion criteria may apply."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01955707", 
            "org_study_id": "101SK201", 
            "secondary_id": "EUDRA CT NO: 2013\u2010001514\u201015"
        }, 
        "intervention": [
            {
                "arm_group_label": "BG00002", 
                "description": "300 mg single intravenous injection", 
                "intervention_name": "BG00002", 
                "intervention_type": "Biological", 
                "other_name": "Natalizumab"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "single intravenous injection", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "March 7, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92103"
                    }, 
                    "name": "University of California San Diego Medical Center"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Golden Valley", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55422"
                    }, 
                    "name": "Minneapolis Clinic of Neurology Ltd"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "66160"
                    }, 
                    "name": "University of Kansas Medical Center"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10467"
                    }, 
                    "name": "Montefiore Medical Center PRIME"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Columbia University Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27710"
                    }, 
                    "name": "Duke University Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Akron", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44307"
                    }, 
                    "name": "Akron General Medical Center"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dayton", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45409"
                    }, 
                    "name": "Miami Valley Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97239"
                    }, 
                    "name": "Oregon Health and Science University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portlnad", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97225"
                    }, 
                    "name": "Providence Stroke Center"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "University of Pennsylvania Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Altenburg", 
                        "country": "Germany", 
                        "zip": "4600"
                    }, 
                    "name": "Klinikum Altenburger Land"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bad Neustadt", 
                        "country": "Germany", 
                        "zip": "97616"
                    }, 
                    "name": "Neurologishce Klinik Bad Neustadt/Saale"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Idar-Oberstein", 
                        "country": "Germany", 
                        "zip": "55743"
                    }, 
                    "name": "Klinikum Idar-Oberstein GmbH"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "8036"
                    }, 
                    "name": "Hospital Clinic I Provincial de Barcelona"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "8035"
                    }, 
                    "name": "Hospital Universitari Vall d'Hebron"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41013"
                    }, 
                    "name": "Hospital Universitario Virgen del Rocio"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Germany", 
                "Spain"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke", 
        "overall_contact": {
            "email": "clinicaltrials@biogenidec.com", 
            "last_name": "Biogen Idec Investigator"
        }, 
        "overall_official": {
            "affiliation": "Biogen Idec", 
            "last_name": "Medical Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Spain: Spanish Agency of Medicines", 
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in Infarct Volume from Baseline (Diffusion-Weighted Imaging [DWI]) to Day 5 (Fluid-Attenuated Inversion Recovery [FLAIR])", 
            "safety_issue": "No", 
            "time_frame": "Day 5"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01955707"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in Infarct Volume From Baseline (DWI) to Day 30 (FLAIR)", 
                "safety_issue": "No", 
                "time_frame": "Day 30"
            }, 
            {
                "measure": "Change in Infarct Volume From 24 hours (DWI) to Day 5 and Day 30 (FLAIR)", 
                "safety_issue": "No", 
                "time_frame": "Up to Day 30"
            }, 
            {
                "measure": "Change in National Institute of Health Stroke Scale (NIHSS) Score from Baseline to 24 hours, Day 5, Day 30, and Day 90", 
                "safety_issue": "No", 
                "time_frame": "Up to Day 90"
            }, 
            {
                "measure": "Modified Rankin Scale (mRS) distribution at Day 5, Day 30, and Day 90", 
                "safety_issue": "No", 
                "time_frame": "Up to Day 90"
            }, 
            {
                "measure": "Barthel Index at Day 5, Day 30, and Day 90", 
                "safety_issue": "No", 
                "time_frame": "Up to Day 90"
            }, 
            {
                "measure": "Number of subjects who experience Adverse Events (AEs) and Serious Adverse Events (SAEs)", 
                "safety_issue": "Yes", 
                "time_frame": "Up to Day 90"
            }
        ], 
        "source": "Biogen Idec", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Biogen Idec", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}